Dr Reddy's Laboratories and Russian Direct Investment Fund (RDIF) on Tuesday said they have commenced adaptive phase 2/3 clinical trials for the Sputnik V COVID-19 vaccine in India. The trials have commenced after receiving the necessary clearance from the Kasauli-based Central Drugs Laboratory, they added.from IndiaTV India: Google News Feed https://ift.tt/3qlPjt9
via
No comments:
Post a Comment
Please do not enter spam link in the comment box. Suggestions are invited for improvement.